packageAmenamevir

amenamevir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Amenamevir is an antiviral drug developed for the treatment of shingles (herpes zoster). It is still investigational and is not authorised in the European Union; it has been used mainly in Japan.

Summary written by glm-5.3-flash from Wikidata Q27271708 and the WHO ATC classification; not checked by a person.

name:amenamevir
ATC codes:J05AX26
DrugBank:DB11701
PubChem CID:11397521
Wikidata:Q27271708
formula:C24H26N4O5S
molar mass:482.555 g/mol (PubChem CID 11397521)
logP:2.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown